"Wir sind ein Krankenhaus an zwei Standorten. Im Standort Aschaffenburg erwarten Sie 22 Kliniken, Abteilungen und Institute. Am Standort Alzenau finden Sie vier medizinische Abteilungen und eine Geriatrische Reha vor. Gemeinsames Ziel: Das Beste für unsere Patienten."

During the past decade, Klinikum Aschaffenburg conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Aschaffenburg" #1 sponsor was "University of Ulm" with 4 trials, followed by "ExThera Medical Europe BV" with 2 trials sponsored, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 2 trials sponsored, "AGO Research GmbH" with 1 trials sponsored and "Aesculap AG" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Aschaffenburg" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "ExThera Medical Corporation" with 2 trials as a collaborator, "Vivantes Clinic Neukölln" with 2 trials as a collaborator, "AGO-B" with 1 trials as a collaborator and "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Aschaffenburg" are "Acute Myeloid Leukemia" (2 trials), "Acute Myeloid Leukemia (AML)" (2 trials), "Adenocarcinoma of the Stomach" (1 trials), "Anaplastic Astrocytoma" (1 trials) and "Arrhythmia" (1 trials). Many other conditions were trialed in "Klinikum Aschaffenburg" in a lesser frequency.

Most popular intervention types in "Klinikum Aschaffenburg" are "Drug" (11 trials), "Device" (4 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (2 trials), "Daunorubicin" (2 trials), "7-day Holter ECG" (1 trials), "Abemaciclib + Aromatase Inhibitor" (1 trials) and "Abemaciclib + Fulvestrant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Aschaffenburg" are 17 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Aschaffenburg". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Klinikum Aschaffenburg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Aschaffenburg, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".

Klinikum Aschaffenburg has several departments that took part in Clinical trials: "II. Medizinische Klinik" - 4 trials, "Hämato-Onkologische Schwerpunktpraxis am Klinikum Aschaffenburg" - 3 trials, "Hämato-onkologischer Studienkreis am Klinikum Aschaffenburg" - 2 trials